Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Azria

Showing results (131-140 of 242) with videos related to

Pageof 25
Sort By:
Radiology|March 23, 2012
MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapyStephanie Nougaret, Philippe Rouanet, Nicolas Molinari, et al.
BMC Cancer|June 22, 2005
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancerDavid Azria, Frederic Bibeau, Nicolas Barbier, et al.
Advances in Radiation Oncology|October 14, 2021
Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Simon Valdenaire, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancerAlexandre Ho-Pun-Cheung, Eric Assenat, Simon Thezenas, et al.
International Journal of Cancer|May 21, 2019
Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trialValérie Boige, Caroline Mollevi, Sophie Gourgou, et al.
Critical Reviews in Oncology/Hematology|September 15, 2025
Individual radiosensitivity testing in 2025: Current advances and future directions for personalized radiotherapyKamel Debbi, Nhu Hanh To, Allan Thiolat, et al.
Bulletin Du Cancer|December 15, 2015
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey]Marc Spielmann, Florence Dalenc, Yoann Pointreau, et al.
Practical Radiation Oncology|October 1, 2018
A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST SurveyYazid Belkacemi, Laurianne Colson-Durand, Maryse Fayolle-Campana, et al.
The Journal of Biological Chemistry|February 2, 2011
Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodiesNadège Gaborit, Christel Larbouret, Julie Vallaghe, et al.
Brachytherapy|July 30, 2017
High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemesAlexander T Falk, Sylvain Demontoy, Emmanuel Chamorey, et al.
Pageof 25

Showing results (131-140 of 242) with videos related to

Sort By:
Pageof 25
Radiology|March 23, 2012
MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapyStephanie Nougaret, Philippe Rouanet, Nicolas Molinari, et al.
BMC Cancer|June 22, 2005
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancerDavid Azria, Frederic Bibeau, Nicolas Barbier, et al.
Advances in Radiation Oncology|October 14, 2021
Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Simon Valdenaire, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancerAlexandre Ho-Pun-Cheung, Eric Assenat, Simon Thezenas, et al.
International Journal of Cancer|May 21, 2019
Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trialValérie Boige, Caroline Mollevi, Sophie Gourgou, et al.
Critical Reviews in Oncology/Hematology|September 15, 2025
Individual radiosensitivity testing in 2025: Current advances and future directions for personalized radiotherapyKamel Debbi, Nhu Hanh To, Allan Thiolat, et al.
Bulletin Du Cancer|December 15, 2015
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey]Marc Spielmann, Florence Dalenc, Yoann Pointreau, et al.
Practical Radiation Oncology|October 1, 2018
A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST SurveyYazid Belkacemi, Laurianne Colson-Durand, Maryse Fayolle-Campana, et al.
The Journal of Biological Chemistry|February 2, 2011
Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodiesNadège Gaborit, Christel Larbouret, Julie Vallaghe, et al.
Brachytherapy|July 30, 2017
High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemesAlexander T Falk, Sylvain Demontoy, Emmanuel Chamorey, et al.
Pageof 25